Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Hecker

Showing results (261-270 of 379) with videos related to

Pageof 38
Sort By:
Journal of Clinical Medicine|June 13, 2025
Discrepancy Between Vaccination Willingness and Actual SARS-CoV-2 Vaccination Status in People with Multiple Sclerosis: A Longitudinal StudyFelicita Heidler, Michael Hecker, Niklas Frahm, et al.
Journal of Proteome Research|December 22, 2012
Novel twin-arginine translocation pathway-dependent phenotypes of Bacillus subtilis unveiled by quantitative proteomicsVivianne J Goosens, Andreas Otto, Corinna Glasner, et al.
Proteomics|August 30, 2012
Partially overlapping substrate specificities of staphylococcal group A sortasesMark J J B Sibbald, Xiao-Mei Yang, Eleni Tsompanidou, et al.
Plos One|January 5, 2012
Reassessment of blood gene expression markers for the prognosis of relapsing-remitting multiple sclerosisMichael Hecker, Brigitte Katrin Paap, Robert Hermann Goertsches, et al.
International Journal of Medical Microbiology : IJMM|February 1, 2014
Activation of the alternative sigma factor SigB of Staphylococcus aureus following internalization by epithelial cells - an in vivo proteomics perspectiveHenrike Pförtner, Marc S Burian, Stephan Michalik, et al.
Therapeutic Advances in Chronic Disease|August 12, 2022
Associated factors of potential drug-drug interactions and drug-food interactions in patients with multiple sclerosisJane Louisa Debus, Paula Bachmann, Niklas Frahm, et al.
Therapeutic Advances in Neurological Disorders|February 8, 2021
Therapeutic plasma exchange in steroid-refractory multiple sclerosis relapses. A retrospective two-center studyStephan Blechinger, Johannes Ehler, Gabriel Bsteh, et al.
Ebiomedicine|May 13, 2022
Implication of genetic variants in primary microRNA processing sites in the risk of multiple sclerosisMichael Hecker, Brit Fitzner, Elena Putscher, et al.
Journal of Bacteriology|October 20, 2009
Diamide triggers mainly S Thiolations in the cytoplasmic proteomes of Bacillus subtilis and Staphylococcus aureusDierk-Christoph Pöther, Manuel Liebeke, Falko Hochgräfe, et al.
Journal of Molecular Microbiology and Biotechnology|October 30, 2008
Cell physiology and protein secretion of Bacillus licheniformis compared to Bacillus subtilisBirgit Voigt, Haike Antelmann, Dirk Albrecht, et al.
Pageof 38

Showing results (261-270 of 379) with videos related to

Sort By:
Pageof 38
Journal of Clinical Medicine|June 13, 2025
Discrepancy Between Vaccination Willingness and Actual SARS-CoV-2 Vaccination Status in People with Multiple Sclerosis: A Longitudinal StudyFelicita Heidler, Michael Hecker, Niklas Frahm, et al.
Journal of Proteome Research|December 22, 2012
Novel twin-arginine translocation pathway-dependent phenotypes of Bacillus subtilis unveiled by quantitative proteomicsVivianne J Goosens, Andreas Otto, Corinna Glasner, et al.
Proteomics|August 30, 2012
Partially overlapping substrate specificities of staphylococcal group A sortasesMark J J B Sibbald, Xiao-Mei Yang, Eleni Tsompanidou, et al.
Plos One|January 5, 2012
Reassessment of blood gene expression markers for the prognosis of relapsing-remitting multiple sclerosisMichael Hecker, Brigitte Katrin Paap, Robert Hermann Goertsches, et al.
International Journal of Medical Microbiology : IJMM|February 1, 2014
Activation of the alternative sigma factor SigB of Staphylococcus aureus following internalization by epithelial cells - an in vivo proteomics perspectiveHenrike Pförtner, Marc S Burian, Stephan Michalik, et al.
Therapeutic Advances in Chronic Disease|August 12, 2022
Associated factors of potential drug-drug interactions and drug-food interactions in patients with multiple sclerosisJane Louisa Debus, Paula Bachmann, Niklas Frahm, et al.
Therapeutic Advances in Neurological Disorders|February 8, 2021
Therapeutic plasma exchange in steroid-refractory multiple sclerosis relapses. A retrospective two-center studyStephan Blechinger, Johannes Ehler, Gabriel Bsteh, et al.
Ebiomedicine|May 13, 2022
Implication of genetic variants in primary microRNA processing sites in the risk of multiple sclerosisMichael Hecker, Brit Fitzner, Elena Putscher, et al.
Journal of Bacteriology|October 20, 2009
Diamide triggers mainly S Thiolations in the cytoplasmic proteomes of Bacillus subtilis and Staphylococcus aureusDierk-Christoph Pöther, Manuel Liebeke, Falko Hochgräfe, et al.
Journal of Molecular Microbiology and Biotechnology|October 30, 2008
Cell physiology and protein secretion of Bacillus licheniformis compared to Bacillus subtilisBirgit Voigt, Haike Antelmann, Dirk Albrecht, et al.
Pageof 38